Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD19 Protein (AA 20-291) (His tag,FITC)

This Recombinant CD19 protein is produced in HEK-293 Cells.
Catalog No. ABIN7274067

Quick Overview for CD19 Protein (AA 20-291) (His tag,FITC) (ABIN7274067)

Target

See all CD19 Proteins
CD19 (CD19 Molecule (CD19))

Protein Type

Recombinant

Origin

  • 32
  • 4
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
Human

Source

  • 27
  • 6
  • 3
  • 3
  • 3
  • 1
  • 1
HEK-293 Cells

Purity

> 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
  • Protein Characteristics

    AA 20-291

    Purification tag / Conjugate

    This CD19 protein is labelled with His tag,FITC.

    Purpose

    FITC-Compatible Human CD19 Protein

    Sequence

    Pro20-Lys291

    Characteristics

    FITC-Compatible Human CD19 Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Pro20-Lys291.

    Sterility

    0.22 μm filtered

    Endotoxin Level

    Less than 1EU per μg by the LAL method.
  • Want other Options for this Protein ?

    !
    Discover Our Predefined Custom Proteins and Custom Protein Services!

    Your project requires further customization? Contact us and discover our custom protein solutions

  • Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Supplied as 0.22 μm filtered solution in PBS ( pH 7.4).

    Storage

    -80 °C

    Storage Comment

    Valid for 12 months from date of receipt when stored at -80°C., Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

    Expiry Date

    12 months
  • Target

    CD19 (CD19 Molecule (CD19))

    Alternative Name

    CD19

    Background

    CD19 is a B-lineage-specific transmembrane glycoprotein, the expression of which is maintained on more than 95 % B-cell malignancies. This strict lineage restriction makes CD19 an ideal target for immune therapies using chimeric antigen receptors (CARs). T cells engineered to express a chimeric antigen receptor (CAR) against CD19 have recently been FDA approved for the treatment of relapsed or refractory large B-cell lymphoma. Despite the success and curative potential of CD19 CAR T cells, several reports describing disease relapse due to antigen loss are now emerging.

    Molecular Weight

    60.1 kDa. Due to glycosylation, the protein migrates to 68-72 kDa based on Tris-Bis PAGE result.

    Pathways

    Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway
You are here:
Chat with us!